FDA approves Pfizer's Humira biosimilar, offers update on progress biosimilar approvalsPfizer plans to launch Humira biosimilar in 2023. The Mane Choice, Mav Beauty Brands form strategic partnershipThe Mane Choice partnered with Mav Beauty Brands to reach to a wider range of consumers across North America, the company said. Abbott Labs CEO to step down, company names successor After 21 years, Miles White is stepping down as Abbott’s CEO next March. The company has named Robert Ford as his successor. Consortium led by Wasson Enterprise to acquire majority stake in Innovation A group of investors led by Greg Wasson, former Walgreens Boots Alliance CEO will acquire a majority stake in Innovation Associates. Mylan-Upjohn combination to be called Viatris The Viatris name will be effective upon closing of the combination of Mylan and Upjohn, which is expected to occur in mid 2020. Henkel acquires DevaCurl DevaCurl’s offerings include cleansers, conditioners, styling products, styling accessories and treatments for all types of curly and wavy hair. Diplomat posts Q3 loss along with drop in PBM segment Diplomat's Q3 revenue was comprised of $1.2 billion from the company’s specialty segment and $82 million from its pharmacy benefit manager segment Teva taps Eli Kalif as executive vice president, CFO Eli Kalif will join Teva as executive vice president and chief financial officer on Dec. 22. KKR reportedly approaches Walgreens Boots Alliance on leveraged buyout Private equity firm KKR has reportedly been preparing a proposal to take Walgreens Boots Alliance private. Foamix, Menlo Therapeutics to merge Foamix and Menlo’s merger will result in a combined company focused on the dermatology space. First Previous 121 122 123 124 125 Next Last
